DANVILLE, PA – Geisinger Medical Center, Geisinger Wyoming Valley Medical Center and Geisinger Community Medical Center have each received the Mission: Lifeline Gold Receiving Quality Achievement Award for implementing specific quality improvement measures as outlined by the American Heart Association for the treatment of patients who suffer severe heart attacks.
Each year, more than 250,000 people experience an ST elevation myocardial infarction (STEMI) the most deadly type of heart attack caused by a blockage of blood flow to the heart that requires timely treatment. To prevent death, it’s critical to restore blood flow as quickly as possible, either by mechanically opening the blocked vessel or by providing clot-busting medication.
The American Heart Association’s Mission: Lifeline program’s goal is to reduce system barriers to prompt treatment for heart attacks, beginning with the 9-1-1 call and continuing through hospital treatment. Geisinger Medical Center, Geisinger Wyoming Valley Medical Center and Geisinger Community Medical Center are each recognized for having an 85 percent composite adherence and at least 24 consecutive months of 75 percent or higher compliance on all Mission: Lifeline STEMI Receiving Center quality measures thus improving the quality of care for STEMI patients.
“Geisinger is dedicated to improving the quality of care for our patients who suffer a heart attack, and the American Heart Association’s Mission: Lifeline program is helping us accomplish that goal by reliably applying nationally respected clinical guidelines,” said Alfred Casale, M.D., director, Geisinger Heart Institute. “We are pleased to be recognized for our dedication and achievements in cardiac care, and I am very proud of our team.”
In addition to receiving the Mission: Lifeline Gold Receiving award, Geisinger Medical Center, Geisinger Wyoming Valley Medical Center and Geisinger Community Medical Center have also been recognized as recipients of Mission: Lifeline’s Gold-Plus award, which recognizes the hospital has not only reached an achievement score of 75 percent or greater on all Mission: Lifeline Receiving Center Quality Measures, but also for achieving at least a 75 percent achievement on First Door to Device time under 120 minutes for STEMI transfer patients from other facilities.
“We commend Geisinger for these achievement awards, which reflects a significant institutional commitment to the highest quality of care for their heart attack patients,” said James G. Jollis, M.D., Chair of the Mission: Lifeline Advisory Working Group. “Achieving this award means the hospitals have met specific reporting and achievement measures for the treatment of their patients who suffer heart attacks and we applaud them for their commitment to quality and timely care.”
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.
About Mission: Lifeline
The American Heart Association’s Mission: Lifeline program helps hospitals and emergency medical services develop systems of care that follow proven standards and procedures for STEMI patients. The program works by mobilizing teams across the continuum of care to implement American Heart Association/American College of Cardiology Foundation clinical treatment guidelines. For more information, visit www.heart.org/missionlifeline and www.heart.org/quality.